Cargando…

Chemotherapy and Other

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2002
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395500/ https://www.ncbi.nlm.nih.gov/pubmed/18521355 http://dx.doi.org/10.1080/135771402753667682

Ejemplares similares

Editorial: Chemotherapy and other pharmacotherapies for canine neurological disorders
por: Bentley, R. Timothy, et al.
Publicado: (2023)

Chemotherapy-induced senescent cancer cells engulf other cells to enhance their survival
por: Tonnessen-Murray, Crystal A., et al.
Publicado: (2019)

Glioblastoma: Pathogenesis and Current Status of Chemotherapy and Other Novel Treatments
por: Rajaratnam, Vilashini, et al.
Publicado: (2020)

Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma
por: Xue, Zhichao, et al.
Publicado: (2020)

Predictive value of topoisomerase IIalpha and other prognostic factors for epirubicin chemotherapy in advanced breast cancer.
por: JÃ¤rvinen, T. A., et al.
Publicado: (1998)

Circulating endothelial cells and other angiogenesis factors in pancreatic carcinoma patients receiving gemcitabine chemotherapy
por: Kondo, Shunsuke, et al.
Publicado: (2012)

Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents
por: Maristany, Sumiko, et al.
Publicado: (2022)

Chemotherapy of Gonorrhœa and Other Minor Venereal Diseases with Sulphanilamide Compounds—A Clinical Study
por: Rajam, R. V., et al.
Publicado: (1939)

Announcement: 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy ISPCC '99
Publicado: (1998)

Announcement: 8th International Symposium on Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy ISPCC '99
Publicado: (1998)

Consumption of Lactose, Other FODMAPs and Diarrhoea during Adjuvant 5-Fluorouracil Chemotherapy for Colorectal Cancer
por: Holma, Reetta, et al.
Publicado: (2020)

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
por: Lee, Lennard YW, et al.
Publicado: (2020)

Rates and risk of arrhythmias in cancer survivors with chemotherapy-induced cardiomyopathy compared with patients with other cardiomyopathies
por: Fradley, Michael G, et al.
Publicado: (2017)

How to Increase the Efficacy of Immunotherapy in NSCLC and HNSCC: Role of Radiation Therapy, Chemotherapy, and Other Strategies
por: Nardone, Valerio, et al.
Publicado: (2018)

Impact of platinum/pemetrexed combination versus other platinum-based regimens on adjuvant chemotherapy in resected lung adenocarcinoma
por: Zhai, Xiaoyu, et al.
Publicado: (2017)

Network meta-analysis of eribulin versus other chemotherapies used as second- or later-line treatment in locally advanced or metastatic breast cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Apatinib monotherapy for advanced non‐small cell lung cancer after the failure of chemotherapy or other targeted therapy
por: Liu, Zui, et al.
Publicado: (2018)

A real-world comparative analysis of carfilzomib and other systemic multiple myeloma chemotherapies in a US community oncology setting
por: Rifkin, Robert M., et al.
Publicado: (2019)

Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis
por: Li, Zhiru, et al.
Publicado: (2022)

A Modified 2 Tier Chemotherapy Response Score (CRS) and Other Histopathologic Features for Predicting Outcomes of Patients with Advanced Extrauterine High-Grade Serous Carcinoma after Neoadjuvant Chemotherapy
por: Zhong, Yanping, et al.
Publicado: (2021)

1677MO COVID-19 mortality in hospitalized cancer patients is not significantly affected by chemotherapy or other anti-cancer treatments
por: Lee, L., et al.
Publicado: (2020)

Difference in Protein Expression Profile and Chemotherapy Drugs Response of Different Progression Stages of LNCaP Sublines and Other Human Prostate Cancer Cells
por: Lin, Hui-Ping, et al.
Publicado: (2013)

A meta-analysis of randomized controlled trials that compare standard doxorubicin with other first-line chemotherapies for advanced/metastatic soft tissue sarcomas
por: Tanaka, Kazuhiro, et al.
Publicado: (2019)

Skeletal Muscle Deconditioning in Breast Cancer Patients Undergoing Chemotherapy: Current Knowledge and Insights From Other Cancers
por: Mallard, Joris, et al.
Publicado: (2021)

Prognostic value of TP53 expression and MGMT methylation in glioblastoma patients treated with temozolomide combined with other chemotherapies
por: Kurdi, Maher, et al.
Publicado: (2021)

Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination
por: Lew, Thomas E., et al.
Publicado: (2022)

Is TIMP-1 immunoreactivity alone or in combination with other markers a predictor of benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial?
por: Munro, Alison F, et al.
Publicado: (2013)

Neoadjuvant chemotherapy with dose dense MVAC is associated with improved survival after radical cystectomy compared to other cytotoxic regimens: A tertiary center experience
por: Lemiński, Artur, et al.
Publicado: (2021)

The Chinese herb Xiaoaiping protects against breast cancer chemotherapy-induced alopecia and other side effects: a randomized controlled trial
por: Yu, Fujie, et al.
Publicado: (2019)

Platinum and other metal coordination compounds in cancer chemotherapy. A commentary on the sixth international symposium: San Diego, California, 23-26th January 1991.
por: McKeage, M. J., et al.
Publicado: (1991)

Chemotherapy for osteosarcoma.
por: Souhami, R. L.
Publicado: (1989)

Evidence for induction of a tumor metastasis-receptive microenvironment for ovarian cancer cells in bone marrow and other organs as an unwanted and underestimated side effect of chemotherapy/radiotherapy
por: Gunjal, Pranesh M, et al.
Publicado: (2015)

Changes of Plasma Interleukin-1 Receptor Antagonist, Interleukin-8 and other Serologic Markers during Chemotherapy in Patients with Active Pulmonary Tuberculosis
por: Lee, Jin Hwa, et al.
Publicado: (2003)

Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future Directions
por: Yardley, Denise A.
Publicado: (2013)

Accuracy of MRI for prediction of response to neo-adjuvant chemotherapy in triple negative breast cancer compared to other subtypes of breast cancer
por: Bansal, Gaurav J, et al.
Publicado: (2016)

Attitudes toward Others Depend upon Self and Other Causal Uncertainty
por: Tobin, Stephanie J., et al.
Publicado: (2014)

Other
Publicado: (2020)

Other voices, other rooms
por: Capote, Truman, 1924-
Publicado: (1948)

Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysis
por: Yang, Xue-Qin, et al.
Publicado: (2015)

Chemotherapy of lung cancer.
por: Papac, R. J.
Publicado: (1981)

Cannot write session to /tmp/vufind_sessions/sess_7qb3ldt8fkle0obaclgd1d1for